Some six years after first conceiving the idea, Herman Goossens has finally succeeded in launching a network, known as GRACE (Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe). It will receive approximately $13.95 million in European Union funding through 2011.
Advertisement
Survey Series
For Advertisers
THE ROUNDUP
Spreading Better Diagnosis
|
|||||||||
|
|||||||||
|
